By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2910 Seventh Street

Berkeley  California  94710  U.S.A.
Phone: 510-204-7200 or 800-BIO-XOMA
Fax: 510-644-0539



Company News
XOMA (US) LLC (XOMA) Call Today At 4:30pm ET/1:30pm PT To Confirm Communication Plan For EYEGUARD®-B Clinical Program 7/1/2014 10:24:13 AM
XOMA (US) LLC (XOMA) To Present At The Jefferies and Co. Global Healthcare Conference 5/29/2014 9:30:36 AM
XOMA (US) LLC (XOMA) Reports First Quarter 2014 Operational Highlights And Financial Results 5/8/2014 9:26:52 AM
XOMA (US) LLC (XOMA) To Announce First Quarter 2014 Financial Results And Host Webcast On May 7 4/30/2014 5:17:44 PM
XOMA (US) LLC (XOMA) Finalizes Plans For Gevokizumab Phase 3 Clinical Program In Pyoderma Gangrenosum 4/28/2014 9:04:04 AM
XOMA (US) LLC (XOMA) Reports 2013 Operational Highlights And Fourth Quarter And Full-Year 2013 Financial Results 3/5/2014 9:19:15 AM
XOMA (US) LLC (XOMA) Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 2/25/2014 9:17:52 AM
XOMA (US) LLC (XOMA) To Present At Upcoming Investor Conferences 2/21/2014 8:43:45 AM
XOMA (US) LLC (XOMA) Announces Closing Of The Offering And Exercise Of Option 12/19/2013 9:21:55 AM
XOMA (US) LLC (XOMA) Announces Pricing Of Approximately $50.0 Million Offering Of Common Stock 12/13/2013 9:16:13 AM